Literature DB >> 1520315

Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.

I Abe1, M Bai, X Y Xiao, G D Prestwich.   

Abstract

Pig and rat liver oxidosqualene cyclase (OSC) enzymes were purified to homogeneity and showed single bands on SDS-polyacrylamide gel electrophoresis with molecular masses of 75 kDa (pig) and 78 kDa (rat). Pig liver OSC was purified for the first time (441-fold with a yield of 39%). Chemical affinity labeling of pure or crude preparations of the liver cyclases using the mechanism-based irreversible inhibitor of OSC, [3H]29-methylidene-2,3-oxidosqualene ([3H]29-MOS), showed a single radioactive band at 75 kDa (pig) and 78 kDa (rat). Affinity labeling experiments were also performed with dog and human microsomal preparations and with yeast and plant cyclases. All of the vertebrate OSC enzymes were specifically labeled with [3H]29-MOS and gave a single band with molecular masses ranging from 70 to 80 kDa (rat, 78 kDa; dog, 73 kDa; pig, 75 kDa; and human, 73 kDa). In contrast, yeast lanosterol cyclase and plant cycloartenol cyclase were not labeled, demonstrating subtle differences in the active sites of animal, plant, and fungal enzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520315     DOI: 10.1016/s0006-291x(05)81454-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase.

Authors:  Maurizio Ceruti; Gianni Balliano; Flavio Rocco; Alexander Lenhart; Georg E Schulz; Francesco Castelli; Paola Milla
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

2.  Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases.

Authors:  M Ceruti; G Balliano; F Rocco; P Milla; S Arpicco; L Cattel; F Viola
Journal:  Lipids       Date:  2001-06       Impact factor: 1.880

3.  Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat.

Authors:  Masayuki Mori; Guixin Li; Ikuro Abe; Jun Nakayama; Zhanjun Guo; Jinko Sawashita; Tohru Ugawa; Shoko Nishizono; Tadao Serikawa; Keiichi Higuchi; Seigo Shumiya
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

4.  Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.

Authors:  R C Goldman; D Zakula; J O Capobianco; B A Sharpe; J H Griffin
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

5.  Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae.

Authors:  Z Shi; C J Buntel; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Identification of the active site of vertebrate oxidosqualene cyclase.

Authors:  I Abe; G D Prestwich
Journal:  Lipids       Date:  1995-03       Impact factor: 1.880

7.  2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.

Authors:  L Cattel; M Ceruti; G Balliano; F Viola; G Grosa; F Rocco; P Brusa
Journal:  Lipids       Date:  1995-03       Impact factor: 1.880

8.  Molecular cloning, characterization, and functional expression of rat oxidosqualene cyclase cDNA.

Authors:  I Abe; G D Prestwich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.